Gyre Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $30,564 | $26,771 | $22,058 | $27,872 |
Gross Profit | 28,936 | 25,620 | 21,164 | 26,695 |
EBITDA | 8,278 | 2,813 | 2,808 | 1,134 |
EBIT | 7,629 | 2,172 | 2,273 | 663 |
Net Income | 3,610 | 442 | 2,698 | -99 |
Net Change In Cash | 30,564 | 26,771 | 22,058 | 27,872 |
Free Cash Flow | 3,993 | 1,809 | -950 | -3,503 |
Cash | 40,402 | 36,491 | 15,045 | 11,813 |
Basic Shares | 102,701 | 102,701 | 101,970 | 102,293 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $105,757 | $113,450 | $102,290 | $7,338 |
Gross Profit | 101,873 | 108,814 | 97,497 | -332 |
EBITDA | 17,817 | 20,327 | 10,332 | -87,643 |
EBIT | 16,229 | 19,213 | 9,203 | -87,933 |
Net Income | 12,085 | -92,933 | 2,302 | -87,933 |
Net Change In Cash | 105,757 | 113,450 | 102,290 | 7,338 |
Free Cash Flow | -6,769 | 17,306 | 5,679 | -84,594 |
Cash | 11,813 | 33,509 | 25,175 | 44,347 |
Basic Shares | 102,293 | 65,831 | 75,686 | 30,640 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | $0.03 |
2025-06-30 | $0.002 |
